SLN – silence therapeutics plc - american depository share (US:NASDAQ)
Stock Stats
News
Silence Therapeutics to Report Fourth Quarter and Full Year 2024 Results on February 27, 2025 [Yahoo! Finance]
Silence Therapeutics to Report Fourth Quarter and Full Year 2024 Results on February 27, 2025
Silence Therapeutics plc (NASDAQ: SLN) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "sell" rating and a $6.00 price target on the stock.
Silence Therapeutics plc (NASDAQ: SLN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $75.00 price target on the stock.
Silence Therapeutics plc (SLN): Among the Oversold Global Stocks to Buy Right Now [Yahoo! Finance]
Form SCHEDULE 13G Silence Therapeutics Filed by: Redmile Group, LLC
Form SCHEDULE 13G/A Silence Therapeutics Filed by: Lombard Odier Asset Management (USA) Corp
Form D Southland Holdings, Inc.
Form 4 Silence Therapeutics For: Jan 02 Filed by: Davidson Michael H.
Form 4 Silence Therapeutics For: Jan 02 Filed by: Ede-Golightly James
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.